NAVIDEA BIOPHARMACEUTICALS I (NAVB) Stock Price, Quote, News and Overview

What is the stock price of NAVIDEA BIOPHARMACEUTICALS I today?

The current stock price of NAVB is 0.0779 USD. The price decreased by -2.99% in the last trading session.

What is the ticker symbol for NAVIDEA BIOPHARMACEUTICALS I stock?

The exchange symbol of NAVIDEA BIOPHARMACEUTICALS I is NAVB and it is listed on the NYSE Arca exchange.

On which exchange is NAVB stock listed?

NAVB stock is listed on the NYSE Arca exchange.

What is the price forecast or stock price prediction for NAVIDEA BIOPHARMACEUTICALS I stock?

7 analysts have analysed NAVB and the average price target is 5.1 USD. This implies a price increase of 6446.85% is expected in the next year compared to the current price of 0.0779. Check the NAVIDEA BIOPHARMACEUTICALS I stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is NAVIDEA BIOPHARMACEUTICALS I worth?

NAVIDEA BIOPHARMACEUTICALS I (NAVB) has a market capitalization of 7.80M USD. This makes NAVB a Nano Cap stock.

How many employees does NAVIDEA BIOPHARMACEUTICALS I have?

NAVIDEA BIOPHARMACEUTICALS I (NAVB) currently has 11 employees.

What are the support and resistance levels for NAVIDEA BIOPHARMACEUTICALS I (NAVB) stock?

NAVIDEA BIOPHARMACEUTICALS I (NAVB) has a resistance level at 0.09. Check the full technical report for a detailed analysis of NAVB support and resistance levels.

Should I buy NAVIDEA BIOPHARMACEUTICALS I (NAVB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of NAVB, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of NAVB, evaluating the profitability, health, valuation and growth aspects
• NAVIDEA BIOPHARMACEUTICALS I (NAVB) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• NAVIDEA BIOPHARMACEUTICALS I (NAVB) Sales and EPS estimates to see what analysts future expectations are.
• NAVIDEA BIOPHARMACEUTICALS I (NAVB) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• NAVIDEA BIOPHARMACEUTICALS I (NAVB) Insider and Institutional Ownership to learn about the owners and their transactions.
• NAVIDEA BIOPHARMACEUTICALS I (NAVB) Stock Chart to make your own analysis
• NAVIDEA BIOPHARMACEUTICALS I (NAVB) Latest news and press-releases to stay up to date.

Does NAVIDEA BIOPHARMACEUTICALS I (NAVB) stock pay dividends?

NAVB does not pay a dividend.

When does NAVIDEA BIOPHARMACEUTICALS I (NAVB) report earnings?

NAVIDEA BIOPHARMACEUTICALS I (NAVB) will report earnings on 2023-11-13, after the market close.

What is the Price/Earnings (PE) ratio of NAVIDEA BIOPHARMACEUTICALS I (NAVB)?

NAVIDEA BIOPHARMACEUTICALS I (NAVB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).

What is the Short Interest ratio of NAVIDEA BIOPHARMACEUTICALS I (NAVB) stock?

The outstanding short interest for NAVIDEA BIOPHARMACEUTICALS I (NAVB) is 0% of its float. Check the ownership tab for more information on the NAVB short interest.

Over the last trailing twelve months NAVB reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS decreased by -39.35% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to NAVB. The Buy consensus is the average rating of analysts ratings from 7 analysts.